Saturday, May 2, 2015
- 5:30pm-7:30pm
-
Should Current IVIg Preparations Containing High Titers of Anti-HLA-I/-II IgG be Used for Lowering the Anti-HLA IgG in Sensitized Pre-Transplant Patients and Allograft Recipients?
Poster Session A: Kidney Antibody Mediated Rejection • Exhibit Hall E
- 5:30pm-7:30pm
-
Similar Outcomes Can Be Expected Among HIV (+) Kidney Transplant Recipients (HIV+ Tx) Vs. HIV (-) Kidney Transplant Recipients (HIV- Tx) Receiving Similar Immunosuppression Protocols
Poster Session A: Infection • Exhibit Hall E
- 5:30pm-7:30pm
-
Single Center Experience With the Use of an Abbreviated Anti-Thymocyte Globulin and Basiliximab Combination Protocol in Renal Transplantation
Poster Session A: Kidney Immunosuppression: Induction Therapy • Exhibit Hall E
- 5:30pm-7:30pm
-
Single Infusion of Donor-Type Splenocytes Treated With Extracorporeal Photopheresis Prior to Transplantation Significantly Prolongs Cardiac Allograft Survival in Mice
Poster Session A: Preclinical Immunosuppression and Tolerance • Exhibit Hall E
- 5:30pm-7:30pm
-
Sofosbuvir Therapy in Early and Late Post Liver Transplant Setting: A Single Center Experience
Poster Session A: Liver Transplantation: Viral Hepatitis • Exhibit Hall E
- 5:30pm-7:30pm
-
Sofosbuvir-Based Therapy for Hepatitis C Recurrence Post Liver Transplantation
Poster Session A: Liver Transplantation: Viral Hepatitis • Exhibit Hall E
- 5:30pm-7:30pm
-
Speed of Onset of Donor Brain Death Leads to Differences in Renal Function and Expression of Inflammatory and Oxidative Stress Markers in Rat Kidneys
Poster Session A: Donor Management: All Organs • Exhibit Hall E
- 5:30pm-7:30pm
-
Survival of Patients With Peripheral Vascular Disease on Kidney Waitlist and After Transplantation: An Analysis of the United State Renal Data System
Poster Session A: Kidney: Cardiovascular and Metabolic • Exhibit Hall E
- «Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 30
- Next Page»